It was a few weeks ago when reports of some drugs were announced as having potential against the Corona Virus, including Chloroquine.
Big pharmaceuticals are stepping up the game to battle CoronaVirus by launching clinical-drug trials.
One such company is Sanofi SA.
Sanofi SA and partner Regeneron Pharmaceuticals Inc started the clinical trial of their rheumatoid arthritis drug Kevzara as a treatment for the coronavirus, the companies said on Monday.
Enrolments for the mid-to-late stage trial will begin immediately, and the companies anticipate the trial will test up to 400 patients.
Kevzara is an infection-fighting protein known as monoclonal antibody.
Regeneron in February announced a partnership with the US Department of Health and Human Services to develop a coronavirus treatment and had said it would focus on monoclonal antibodies.
